{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:04:20Z","timestamp":1761581060233},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.urology.2012.10.068","type":"journal-article","created":{"date-parts":[[2013,2,6]],"date-time":"2013-02-06T20:36:50Z","timestamp":1360183010000},"page":"837-843","source":"Crossref","is-referenced-by-count":4,"title":["Potential Consequences of Low Biopsy Core Number in Selection of Patients With Prostate Cancer for Current Active Surveillance Protocols"],"prefix":"10.1016","volume":"81","author":[{"given":"Georg","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gernot","family":"Bonkat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malte","family":"Rieken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen F.","family":"Wyler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Bubendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"P\u00fcschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Gasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrill A.","family":"Rentsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2012.10.068_bib1","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.eururo.2009.02.028","article-title":"Insignificant prostate cancer and active surveillance: from definition to clinical implications","volume":"55","author":"Bastian","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2012.10.068_bib2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.1994.03510290050036","article-title":"Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer","volume":"271","author":"Epstein","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2012.10.068_bib3","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.eururo.2007.05.011","article-title":"Prospective validation of active surveillance in prostate cancer: the PRIAS study","volume":"52","author":"van den Bergh","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2012.10.068_bib4","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/cncr.23827","article-title":"Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features","volume":"113","author":"Suardi","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2012.10.068_bib5","first-page":"1643","article-title":"Laparoscopic radical prostatectomy: the Montsouris technique","volume":"163","author":"Guillonneau","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2012.10.068_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00345-002-0265-4","article-title":"The endoscopic extraperitoneal radical prostatectomy (EERPE): technique and initial experience","volume":"20","author":"Stolzenburg","year":"2002","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2012.10.068_bib7","series-title":"AJCC Cancer Staging Manual","author":"Greene","year":"2002"},{"key":"10.1016\/j.urology.2012.10.068_bib8","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","article-title":"The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma","volume":"29","author":"Epstein","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urology.2012.10.068_bib9","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/cncr.20586","article-title":"Characteristics of insignificant clinical T1c prostate tumors: a contemporary analysis","volume":"101","author":"Bastian","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2012.10.068_bib10","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1464-410X.2009.09070.x","article-title":"Application of the Epstein criteria for prediction of clinically insignificant prostate cancer in Korean men","volume":"105","author":"Lee","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2012.10.068_bib11","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2007.11.057","article-title":"Validation of the contemporary Epstein criteria for insignificant prostate cancer in European men","volume":"54","author":"Jeldres","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2012.10.068_bib12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1464-410X.2011.09979.x","article-title":"Epstein criteria for insignificant prostate cancer","volume":"108","author":"Oon","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2012.10.068_bib13","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/cncr.24882","article-title":"Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes?","volume":"116","author":"van den Bergh","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2012.10.068_bib14","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/j.1464-410X.2009.09057.x","article-title":"Testing the most stringent criteria for selection of candidates for active surveillance in patients with low-risk prostate cancer","volume":"105","author":"Suardi","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2012.10.068_bib15","first-page":"1605","article-title":"Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review","volume":"175","author":"Eichler","year":"2006","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2012.10.068_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7140","article-title":"Prostate testing for cancer and treatment (ProtecT) feasibility study","volume":"7","author":"Donovan","year":"2003","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.urology.2012.10.068_bib17","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.urology.2008.10.048","article-title":"Biopsy core number represents one of foremost predictors of clinically significant Gleason sum upgrading in patients with low-risk prostate cancer","volume":"73","author":"Capitanio","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.urology.2012.10.068_bib18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.urology.2007.11.094","article-title":"Staging saturation biopsy in patients with prostate cancer on active surveillance protocol","volume":"71","author":"Abouassaly","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.urology.2012.10.068_bib19","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.eururo.2009.07.053","article-title":"The role of biopsy core number in selecting prostate cancer patients for active surveillance","volume":"56","author":"Ploussard","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2012.10.068_bib20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1200\/JCO.2009.24.2180","article-title":"Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer","volume":"28","author":"Klotz","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.urology.2012.10.068_bib21","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1001\/jama.299.23.2760","article-title":"Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy","volume":"299","author":"Trock","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2012.10.068_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/jama.294.4.433","article-title":"Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy","volume":"294","author":"Freedland","year":"2005","journal-title":"JAMA"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429512015063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429512015063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T23:25:01Z","timestamp":1539905101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429512015063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0090429512015063"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2012.10.068","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}